Biotechnology Focus

BioFocus AugSept2017_digital

Biotechnology Focus is Canada's leading authority on Canada's life science news. From biopharma and healthcare to ag-bio and clean tech, our readership includes life science professionals, C-level executives and researchers.

Issue link:

Contents of this Issue


Page 11 of 31

HealtHCaRe innovatoRs HealtHcare 12 BIOTECHNOLOGY FOCUS August/September 2017 t he path from idea to innovation adoption is traditionally not a straight line and can be hard to navigate. Ontario's Innovation Brokers program aims to help innovators identify opportunities for support, refine their business models, land a validation test site in a research hospital, and navigate other challenges along their path to successful adoption. Announced by Ministers Eric Hoskins and Reza Moridi in April 2017, the program is a new initiative of the Office of the Chief Health Innovation Strategist. "Our goal is to use the power of technology to deliver on the needs and goals of patients and the health system," said William Charnetski, Ontario's Chief Health Innovation Strategist. "The bro- kers provide a necessary link between those who need to work together to accelerate the spread of effective health innovations so as to benefit patients, the healthcare system, and Ontario's economy." The mandate of the innovation brokers is to work with innovators and health service providers to bolster innovation across the province. This means helping remove barriers so that new innovative technologies and pro- cesses get into our health care system and to patients faster. The brokers also link growing Ontario-based health technology companies with opportunities, key players, and support. The aim is to create and enhance the connec- tions and collaboration that help ensure suc- cess. To achieve these goals, the brokers also work with health system partners to improve access to sources of support, make it easier to identify test sites for gathering feedback from patients and clinicians, and offer guidance and mentorship in moving innovative ideas from development to adoption and diffusion in Ontario's health system. The first three brokers have distinct but complementary roles. For instance, Azimuth Health Group recently launched @3iOntario, a web service that provides weekly updates of opportunities that innovators and innovation champions can take advantage of to advance their best ideas for improving health and healthcare. The service also shares requests for comment on policy directions and recent publications related to health innovation. It fo- cuses on health technology, including digital health solutions and medical devices. "Large companies have dedicated staff who seek support for their research and de- velopment, commercialization, and growth; small ones rarely do," said Jennifer Zelmer, president of Azimuth Health Group. "We're al- ready hearing from innovators who are taking advantage of opportunities that they learned about via @3iOntario to accelerate their work HelPinG CleaR tHe PatH to tHe maRket foR | bY THE INNoVATIoN bRokERS TEAM a new approach which links ontario-based health technology companies with opportunities, key players, and support

Articles in this issue

view archives of Biotechnology Focus - BioFocus AugSept2017_digital